Abrus Precatorius

Bitki adı: Abrus Precatorius
Bilimsel adı: Abrus precatorius
Cins: Abrus
Familya: Fabaceae

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Takeda
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Takeda
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Broun
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Lewis
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb29: 317
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb24: 243
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Pittier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Brutus
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb29: 317
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Woi.1
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb28: 16
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Broun
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Broun
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb32: 281
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Eb30: 123
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Ayensu
Kaynak: James A. Duke

Bilimsel Araştırmalar

Diabetes mellitus is one of the major health problems in the world, the incidence and associated mortality are increasing. Inadequate regulation of the blood sugar imposes serious consequences for health. Conventional antidiabetic drugs are effective, however, also with unavoidable side effects. On the other hand, medicinal plants may act as an alternative source of antidiabetic agents. Examples of medicinal plants with antidiabetic potential are described, with focuses on preclinical and clinical studies. The beneficial potential of each plant matrix is given by the combined and concerted action of their profile of biologically active compounds.

Makaleyi görüntüle
Plants produce a wide diversity of secondary metabolites (SM) which serve them as defense compounds against herbivores, and other plants and microbes, but also as signal compounds. In general, SM exhibit a wide array of biological and pharmacological properties. Because of this, some plants or products isolated from them have been and are still used to treat infections, health disorders or diseases. This review provides evidence that many SM have a broad spectrum of bioactivities. They often interact with the main targets in cells, such as proteins, biomembranes or nucleic acids. Whereas some SM appear to have been optimized on a few molecular targets, such as alkaloids on receptors of neurotransmitters, others (such as phenolics and terpenoids) are less specific and attack a multitude of proteins by building hydrogen, hydrophobic and ionic bonds, thus modulating their 3D structures and in consequence their bioactivities. The main modes of action are described for the major groups of common plant secondary metabolites. The multitarget activities of many SM can explain the medical application of complex extracts from medicinal plants for more health disorders which involve several targets. Herbal medicine is not a placebo medicine but a rational medicine, and for several of them clinical trials have shown efficacy.

Makaleyi görüntüle
Cancer is the second leading cause of death worldwide. Although great advancements have been made in the treatment and control of cancer progression, significant deficiencies and room for improvement remain. A number of undesired side effects sometimes occur during chemotherapy. Natural therapies, such as the use of plant-derived products in cancer treatment, may reduce adverse side effects. Currently, a few plant products are being used to treat cancer. However, a myriad of many plant products exist that have shown very promising anti-cancer properties in vitro, but have yet to be evaluated in humans. Further study is required to determine the efficacy of these plant products in treating cancers in humans. This review will focus on the various plant-derived chemical compounds that have, in recent years, shown promise as anticancer agents and will outline their potential mechanism of action.

Makaleyi görüntüle
The enzymic degradation of insoluble polysaccharides is one of the most important reactions on earth. Despite this, glycoside hydrolases attack such polysaccharides relatively inefficiently as their target glycosidic bonds are often inaccessible to the active site of the appropriate enzymes. In order to overcome these problems, many of the glycoside hydrolases that utilize insoluble substrates are modular, comprising catalytic modules appended to one or more non-catalytic CBMs (carbohydrate-binding modules). CBMs promote the association of the enzyme with the substrate. In view of the central role that CBMs play in the enzymic hydrolysis of plant structural and storage polysaccharides, the ligand specificity displayed by these protein modules and the mechanism by which they recognize their target carbohydrates have received considerable attention since their discovery almost 20 years ago. In the last few years, CBM research has harnessed structural, functional and bioinformatic approaches to elucidate the molecular determinants that drive CBM-carbohydrate recognition. The present review summarizes the impact structural biology has had on our understanding of the mechanisms by which CBMs bind to their target ligands.

Makaleyi görüntüle

Kaynaklar ve Görseller

« Abies Webbiana Abrus pulchellus »